Article
Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
12 Apr 2018
Abstract excerpt
Chronic infection with the hepatitis B virus (HBV) is a global health concern and accounts for approximately 1 million deaths annually. Amongst other limitations of current anti-HBV treatment, failure to eliminate the viral covalently closed circular DNA (cccDNA) and emergence of resistance remain the most worrisome. Viral rebound from latent episomal cccDNA reservoirs occurs following cessation of therapy,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
